Showing results (531-540 of 542) with videos related to

Sort By:
Pageof 55
Nature Communications|January 7, 2026
Efficacy and safety of low-dose interleukin 2 for Behçet's syndrome: a randomized, placebo-controlled, double-blind, phase 2 clinical trialTian Liu, Wenyan Zhou, Yan Zhu, et al.
Frontiers in Oncology|August 19, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinomaKe Su, Lu Guo, Kun He, et al.
Annals of the Rheumatic Diseases|September 21, 2019
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trialJing He, Ruijun Zhang, Miao Shao, et al.
Nucleic Acids Research|December 21, 2004
The Rat Genome Database (RGD): developments towards a phenome databaseNorberto de la Cruz, Susan Bromberg, Dean Pasko, et al.
Integrative Medicine Research|November 17, 2022
A national survey on how to improve traditional Chinese medicine learning internationally: Perceptions from both teachers and studentsYuhang Zhu, Yan Wu, Hao Zhang, et al.
Clinical and Translational Medicine|August 27, 2025
Molecular architecture of language-related cortical areas revealed by integrative proteomic and connectome analysesJinsong Wu, Zixian Wang, Fengjiao Li, et al.
Physiological Genomics|August 18, 2005
Tools and strategies for physiological genomics: the Rat Genome DatabaseSimon N Twigger, Dean Pasko, Jeff Nie, et al.
Hepatology International|June 21, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching studyKe Su, Tao Gu, Ke Xu, et al.
JAMA Network Open|November 10, 2022
Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome: A Randomized Clinical TrialJing He, Jiali Chen, Miao Miao, et al.
Hepatology International|August 16, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter studyKe Su, Yanlin Liu, Pan Wang, et al.
Pageof 55